T1	Participants 79 145	children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease
T2	Participants 422 524	Children < or =21 years old with biopsy-proven, pathologically staged I, IIA, or IIIA1 Hodgkin disease
T3	Participants 366 420	pediatric and adolescent patients with Hodgkin disease
